Recruiting APOLLO: Personalized rehAbilitation PrOgram in aLLOgeneic Bone Marrow Transplantation NCT05579678 Conditions Allogeneic Disease Locations University of Alberta — Edmonton, Alberta, Canada View Trial Details
Not Yet Recruiting Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML NCT07157514 Conditions Acute Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, +15 more Locations Not specified View Trial Details
Not Yet Recruiting Wharton Jelly Mesenchymal Stromal Cells as GVHD Prophylaxis NCT05855707 Conditions Allogeneic Disease, GVHD,Acute, Graft Failure Locations Not specified View Trial Details
Completed Cancer Rehab Program for Allogenic Bone and Marrow Transplant Patients - CaRE-4-alloBMT NCT04966156 Conditions Allogeneic Disease, Cancer Rehabilitation, Hematologic Cancer, +5 more Locations Princess Margaret Cancer Centre — Toronto, Ontario, Canada View Trial Details
Completed Methyl-qPCR : a New Predictive Marker for Epstein-Barr Virus-associated Lymphoproliferations During Allogeneic Hematopoietic Stem Cell Transplantation NCT03343834 Conditions Allogeneic Disease, Epstein-Barr Viraemia, Hematologic Diseases, +1 more Locations Service d'hématologie Clinique — Paris, France View Trial Details
